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Abstract: Bilateral salpingo-oophorectomy (BSO) in carriers of BRCA1 and BRCA2 mutations 
is widely recommended as part of a risk-reduction strategy for ovarian or breast cancer due to 
an underlying genetic predisposition. BSO is also performed as a therapeutic intervention for 
patients with hormone-positive premenopausal breast cancer. BSO may be performed via a 
minimally invasive approach with the use of three to four 5 mm and/or 12 mm ports inserted 
through a skin incision. To further reduce the morbidity associated with the placement of mul-
tiple port sites and to improve cosmetic outcomes, single-port laparoscopy has been developed 
with a single access point from the umbilicus. The purpose of this study was to evaluate the 
surgical outcomes associated with reducing the risks of salpingo-oophorectomy performed in 
a single port, while comparing multiport laparoscopy in women with a high risk for ovarian 
cancer. Single-port laparoscopy–BSO is feasible and safe, with favorable surgical and cosmetic 
outcomes when compared to conventional laparoscopy.
Keywords: prophylactic salpingectomy, single-port access laparoscopy, BRCA carriers
Introduction
Women with BRCA1 or BRCA2 mutations have a 60%–80% cumulative lifetime risk 
(to 70 years of age) of developing invasive breast cancer and a 15%–65% cumulative 
lifetime risk of invasive epithelial ovarian cancer.1 Bilateral salpingo-oophorectomy 
(BSO) in carriers of BRCA1 and BRCA2 mutations is widely recommended to help 
reduce the risk of ovarian or breast cancer due to an underlying genetic predisposition. 
BSO is also performed as a therapeutic intervention for patients with hormone-positive 
premenopausal breast cancer. Preventive oophorectomy has been associated with an 
80% reduction in the risk of ovarian, fallopian tube, or peritoneal cancer in BRCA1 
or BRCA2 carriers, and a 77% reduction in all-cause mortality.2 Increased knowledge 
and availability of genetic testing has increased the number of women who are able 
to identify their risk for the eventual development of breast cancer or ovarian and/or 
endometrial cancer. This has led many women to consider asking for surgical prophy-
lactic treatment to decrease the potential risk of developing a malignant disease.
The risks and benefits of salpingo-oophorectomy should be weighed, including the 
degree of protection against cancer and the consequences of induced surgical meno-
pause on health and quality of life.3,4 BSO may be performed via a minimally invasive 
approach with the use of three to four 5 mm and/or 12 mm ports inserted through skin 
incisions. To further reduce the morbidity associated with the placement of multiple 
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port sites, and to improve the cosmetic outcomes, single-port 
access laparoscopy (SPAL) has played an increasing role 
in gynecology.5,6 Although the feasibility of this procedure 
has been established, it is still unclear if real advantages 
exist in performing SPAL versus conventional multiport 
laparoscopy (MPL).7–9 The purpose of this study was to 
evaluate the surgical outcomes of prophylactic single-port 
salpingo-oophorectomy compared to conventional MPL in 
women with a high risk for ovarian cancer. 
Materials and methods
This was a prospective, multicentric, case–control study of 
patients with a high risk for ovarian cancer undergoing a 
BSO. BSOs were performed between June 2008 and March 
2014 in the Division of Obstetrics and Gynecology of Cagliari 
(a university hospital in Cagliari, Italy), the Division of 
Gynecology and Obstetrics of Pisa (University of Pisa, Pisa, 
Italy), the Division of Obstetrics and Gynecology, Ospedale 
S Chiara (Trento, Italy), and the Division of Obstetrics and 
Gynecology of Padua (University of Padova, Padua, Italy).
The inclusion criteria were gene-status BRCA1 and 
BRCA2 carriers and women with hormone-positive premeno-
pausal breast cancer. Cervix cytology and transvaginal sonog-
raphy evaluations were performed to confirm any suspicion of 
malignancy, and even the possibility of deep endometriosis.10 
An office diagnostic hysteroscopy with a biopsy ruled out 
any potential intrauterine diseases.11 Other exclusion criteria 
were anesthetic contraindication or a desire of the patient 
to maintain the ovaries.12 The study was approved by the 
local ethics committees (Department of Surgical Sciences, 
Cagliari; University of Pisa; University of Padua; Ospedale 
S. Chiara Trento), and before entering the study, all eligible 
patients received oral and written information about the trial 
by the clinicians and gave their consent. 
Ninety-nine out of 115 patients met the inclusion crite-
ria and entered the study. In each center, the patients were 
informed about the two types of surgeries and were alterna-
tively assigned to undergo an SPAL-BSO performed by four 
surgeons (SA, PL, VC, and LM) with optimal laparoscopic 
experience and at least 1 year of training for this procedure, 
or an MPL-BSO performed by skilled laparoscopic surgeons 
without SPAL experience. They were also informed that 
additional incisions might be necessary during the surgical 
procedure for the single-port laparoscopy. 
Upon agreeing to participate in the study, patients were 
asked to complete baseline questionnaires that included 
their sociodemographic data and medical history. Prospec-
tive data of these patients were collected until March 2014. 
These data included patient characteristics (age and body 
mass index [BMI] [kg/m2]), comorbidity, type and duration 
of surgery, estimated blood loss, postoperative pain score, 
perioperative complications, length of hospital stay, use of 
analgesics, and cosmetic satisfaction. At the end of each 
procedure, intraoperative data – trocar introducing time, 
operative time, estimated blood loss, intra- and periopera-
tive complications, and conversion to standard multiaccess 
laparoscopy or laparotomy – were registered. 
Operative time was defined as the time from umbilical 
skin incision to completion of skin closure. Postoperative 
pain intensity was rated at rest using the visual analog scale 
(VAS). The scale was presented as a 10 cm line, with a verbal 
descriptor anchored with “no pain” and “worst imaginable 
pain”. Patients were asked to rate their pain intensity at 
6 hours, 12 hours, and 24 hours after surgery. 
Patient cosmetic satisfaction was assessed using the Body 
Image Questionnaire (BIQ) at baseline, 1 week, 4 weeks, 
and 24 weeks postsurgery. Subjects were asked to complete 
the BIQ at each visit before seeing their clinician. The BIQ 
consisted of eight questionnaires in two domains: the Body 
Image Scale (BIS) and the Cosmetic Scale (CS). Cronbach’s 
alpha for body image and cosmetic satisfaction were 0.81 
and 0.70, respectively. The maximum scores for BIS and CS 
were 20 and 24, respectively.13
A regression modeling analysis was preliminary per-
formed to evidence any significant difference in outcomes 
among the surgeons of the two groups. The Kolmogorov–
Smirnov test was used to evaluate whether values had a 
Gaussian distribution in order to choose between paramet-
ric and nonparametric statistical tests. Comparisons of the 
proportions and means between groups were done by using 
the χ2 test and independent t-tests, respectively. Statistical 
differences between repeated measurements were computed 
using the paired t-test or the Wilcoxon matched pairs test for 
nonparametric values, both in the case of two comparisons. 
The analysis of variance for repeated measures and the Fried-
man test were used for parametric and nonparametric data, 
respectively. Statistical significance was set at P,0.05.
Surgery
All patients included in the study were admitted to the 
hospital 1 day before surgery. Standard bowel preparation 
was indicated, and prophylactic antibiotic therapy (2 g of 
cefazolin) was administrated 30 minutes preoperatively and 
again postoperatively. Both SPAL-BSO and MPL-BSO were 
performed under general endotracheal anesthesia with the 
patient in the dorsal lithotomy position. A Foley catheter 
was inserted into the bladder, and then a uterine manipu-
lator was applied. In both procedures, a pelvic washing 
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and an abdominal exploration were performed. The right 
infundibulopelvic ligament was skeletonized and transected 
at least 2 cm below the ovarian tissue proper using a 5 mm 
ENSEAL® Trio Device (Ethicon, Inc., Somerville, NJ, USA). 
The right fallopian tube and mesosalpinx were dissected, and 
the utero–ovarian ligament was transected. The same proce-
dure was repeated on the contralateral side. The adnexae were 
placed in a 10 mm specimen retrieval bag (ENDOPOUCH®; 
Ethicon, Inc.), and the specimens were removed. To prevent 
or decrease the occurrence of postsurgical adhesions, 500 mL 
of warm lactated Ringer’s solution was instilled in the pelvis 
at the end of the procedures.14 The extracted specimens were 
sent for histologic examination, and a Foley vesical catheter 
was maintained until the morning after surgery. 
Hemoglobin concentration was determined in all patients 
6 hours after surgery. All patients were permitted sips of 
water starting 6 hours after surgery, and a clear liquid diet 
was offered as the first meal after passing flatus. If pain 
control was needed, 30 mg of ketorolac was administered 
intravenously. The patients were encouraged to ambulate 
starting the first postoperative day.
All surgical specimens were sent for pathologic evalua-
tion. The ovaries were sectioned along the major axis in order 
to produce 2 mm thick sections. The tubes were analyzed 
completely and were cut into sections of 2 mm or 3 mm in 
transversal thickness. The fimbria, which is known to be the 
preferential seat of occurrence of tubal carcinoma, was cut 
into longitudinal sections.
Single-port technique
A 2 cm intraumbilical vertical skin incision and a 2–2.5 cm 
rectus fasciotomy were performed to enter the peritoneal 
cavity, as previously described.15 A reusable single-port 
trocar (S-Portal X-Cone; KARL STORZ GmbH & Co. 
KG, Tuttlingen, Germany) was inserted into the abdominal 
cavity, and the abdomen was insufflated to 12 mmHg. The 
single-port trocar device allows the simultaneous passage of 
various laparoscopic instruments through one small open-
ing and has the added advantage of being reusable. A rigid, 
30°, 5 mm diameter, 50 cm length, Hopkins high-definition 
three-chip camera (KARL STORZ GmbH & Co. KG) was 
routinely used.
At the end of the procedures, specimens were removed 
through the umbilicus after first removing the port device. 
Multiport access technique
For conventional laparoscopy, we used a closed technique, 
preinflating the peritoneal cavity with CO
2
 through a 
hollow insufflation needle (Veress needle) via a midline 
infraumbilical incision. Following pneumoperitoneum, an 
umbilical 10 mm trocar for a 0° telescope was made. Three 
additional trocars (5–10 mm) were then inserted in the lower 
abdominal quadrants under direct laparoscopic vision, as 
previously described.16 Specimens were removed through a 
sovrapubic incision.
Results
Patient characteristics are shown in Table 1. The surgical 
treatment allocation did not determine any withdrawals from 
the study. In total, we performed 99 surgical procedures: 49 
SPAL-BSO (group A) and 50 MPL-BSO (group B). There 
were no differences in the demographic and preoperative 
data between the two groups.
Port placement was successful in all patients, and there 
were no vascular or visceral injuries, loss of pneumoperi-
toneum, or intraoperative port site bleeding. None of the 
patients were converted to a laparotomy. There was no 
conversion to MPL or the need for additional ports. No post-
operative complications were observed in either group. The 
preliminary regression modeling analysis that was performed 
did not yield evidence of any significant difference in the 
outcomes among the surgeons in the two groups.
The SPAL-BSO mean operative time was statistically 
significantly lower than that of the MPL (35.32±13 minutes 
versus 40.02±10 minutes, respectively; P=0.02). The time 
of entry into the abdominal cavity was significantly lower in 
group A (4.15±2 minutes versus 9.12±3.10 minutes, respec-
tively; P,0.001), as was the extraction time of the specimens 
(1.15±1.5 minutes versus 5.30±3.10 minutes, respectively; 
P,0.001) (Table 2). Moreover, the SPAL group had a shorter 
postoperative hospital stay compared to the conventional 
MPL group, but without significance (1.95±0.35 days versus 
2.38±0.43 days, respectively; P=0.08). 
Table 1 characteristics of the patients
Characteristics SPAL (n=49) MPL (n=50)
Age, mean (Sd), years 45.30±7.67 45.74±8.19
BMI (Sd), kg/m2 23.80±2.2 22.22±1.7
Gene status:
BRCA1 30 (61.2%) 29 (58%)
BRCA2 15 (30.6%) 16 (32%)
unknown 4 (8.2%) 5 (10%)
Breast cancer 25 (51%) 28 (56%)
Active treatment 12 (24.5%) 10 (20%)
cBcS 4 (8%) 6 (12%)
Note: Active treatment = chemotherapy.
Abbreviations: SPAl, single-port access laparoscopy; n, number; MPl, multiport 
access laparoscopy; Sd, standard deviation; BMI, body mass index; cBcS, concurrent 
breast cancer surgery (quadrantectomy).
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Pain measured immediately after surgery in the recovery 
unit was lower in the SPAL-BSO group than in the MPL-BSO 
group. Moreover, postoperative pain scores after 6 hours, 
12 hours, and 24 hours were lower in the SPAL-BSO group 
compared with the MPL-BSO group (Table 2).
The BIS and CS scores at 1 week, 4 weeks, and 24 weeks in 
the two groups are shown in Figures 1 and 2. At 1 week and 4 
weeks after surgery, the mean (± standard deviation) BIS score 
in the SPAL-BSO group was significantly higher (18.90±0.69 
and 19.65±0.54, respectively; P,0.001). At 24 weeks after 
surgery, the BIS score was still higher in the SPAL-SH group 
compared with the MPL-BSO group (P,0.001). The CS 
scores at 1 week and 4 weeks after surgery were also higher in 
the SPAL-BSO group than in the MPL-BSO group (P,0.001) 
and the result was maintained at 48 weeks (23.65±1.06 versus 
15.71±0.78, respectively; P,0.001). 
Discussion
Women with mutations in the BRCA1 and BRCA2 gene have 
a higher risk of developing ovarian cancer, but there are cur-
rently no screening protocols for ovarian cancer. Adhesion to 
strict observation protocols can determine a diagnosis at the 
earliest stages of the tumor, but it does not affect mortality. 
The cell of origin of ovarian cancer and the mechanisms by 
which cancer develops have long been debated. There is 
mounting evidence that type I and type II ovarian tumors 
develop independently along different molecular pathways, 
and that both types develop in the fallopian tube and involve 
it secondarily.17 For this reason, patients who are carriers of 
BRCA mutations are candidates for BSO. The timing for 
performing BSO is crucial; it should be proposed to women 
of childbearing age, 35–40 years, who already had or do not 
wish to have children. Bilateral salpingectomy and delaying 
Table 2 Operative outcomes of SPAl versus MPl
Outcomes SPAL-BSO (n=49) MPL-BSO (n=50) P-value
Operative time (minutes) 35.32±13 40.02±10 0.02
Time to enter the abdominal cavity (minutes) 4.15±2 9.12±3.10 ,0.001
Time to specimen extraction (minutes) 1.15±1.5 5.30±3.10 ,0.001
length of stay (days) 1.95±0.35 2.38±0.43 0.08
Postoperative complications 0 (0%) 0 (0%) –
Postoperative pain
Immediately postoperative 5.22±0.83 8.25±1.12 ,0.001
At 6 hours 5.96±0.73 7.88±0.79 ,0.001
At 12 hours 4.65±1.12 6.47±0.84 ,0.001
At 24 hours 1.83±0.98 3.85±1.12 ,0.001
Abbreviations: SPAl, single-port access laparoscopy; MPl, multiport access SPAl-BSO, single port access laparoscopy-bilateral salpingo-oophorectomy; MPl-BSO, 
multiport access laparoscopy-bilateral salpingo-oophorectomy.
Figure 1 Body Image Score at 1 week, 4 weeks, and 24 weeks after surgery.
Note: Body Image Score was significantly higher in the SPAL group in comparison to the 
MPl group at 1 week, 4 weeks, and 24 weeks after surgery, respectively. *P,0.001.
Abbreviations: SPAl-BSO, single port access laparoscopy-bilateral salpingo-
oophorectomy; MPl-BSO, multiport access laparoscopy-bilateral salpingo-oophorectomy; 
SPAl, single-port access laparoscopy; MPl, multiport access laparoscopy; BIS, body 
image score.
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Figure 2 cosmetic satisfaction at 1 week, 4 weeks, and 24 weeks after surgery.
Notes: Cosmetic satisfaction was significantly higher in the SPAL group in comparison to 
the MPl group at 1 week, 4 weeks, and 24 weeks after surgery, respectively. *P,0.001.
Abbreviations: SPAl-BSO, single port access laparoscopy-bilateral salpingo-
oophorectomy; MPl-BSO, multiport access laparoscopy-bilateral salpingo-oopho-
rectomy; SPAl, single-port access laparoscopy; MPl, multiport access laparoscopy
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ovariectomy after pregnancy could also be proposed in 
selected patients.18 The decision to undergo surgery is dif-
ficult. On the one hand, there is the possibility of neoplastic 
disease, while on the other hand, patients are faced with the 
psychological burden of surgical menopause, as well as the 
risks and cosmetic damage related to the surgery itself. Thera-
peutic BSO is even frequently proposed in patients previously 
treated for hormonal-dependent breast carcinoma.19
Open surgery facilitates the intervention by the surgeon; 
however, recent progress and development in the laparo-
scopic technique do not indicate its use for this type of sur-
gery. Numerous studies have demonstrated that laparoscopic 
approaches to various gynecologic oncology conditions, 
including early-stage endometrial cancer, cervical cancer, 
and selected pelvic masses, are feasible and result in shorter 
hospital stays and improved quality of life.20,21
The SPAL is an important development as a new laparo-
scopic technique.5–9 This technique, which is based on reducing 
the invasiveness and increasing the acceptability and esthetic 
results of the classic laparoscopic technique, consists of the 
introduction of a single-port access system through a natural 
scar, the umbilicus. This access system accommodates both the 
instruments and the camera, eliminating the need for multiple 
separate trocars required by traditional laparoscopic surgery.
One of the major benefits of the SPAL surgery is purport-
edly the best esthetic outcome. To date, however, there has 
been no conclusive evidence supporting this,22–24 and some 
studies have not shown any superiority of the single-port 
access over conventional laparoscopic procedures. Lee et al25 
demonstrated that SPAL adnexal surgery had comparable 
operative outcomes to conventional laparoscopic adnexal 
surgery. In a randomized controlled trial, Song et al24 com-
pared cosmetic satisfaction from laparoendoscopic single-
site hysterectomy with multiport surgery. The SPAL group 
reported significantly higher cosmetic satisfaction at 1 week, 
4 weeks, and 24 weeks after surgery. Moreover, a recent 
study evidenced the benefit in relation to body image and 
cosmesis in SPAL subtotal hysterectomy.26 Our study also 
showed that cosmetic results were significantly higher in the 
SPAL group compared to the MPL group.
Regarding postoperative pain, Kim et al27,28 showed 
a reduction in postoperative pain scores, but with similar 
perioperative outcomes with SPAL surgery compared to 
traditional laparoscopy in adnexal pathology and LAVH. 
Another randomized controlled trial showed that single-site 
access provides an advantage over conventional multiaccess 
laparoscopy in terms of postoperative pain and the need for 
rescue analgesia, with similar perioperative outcomes.29 
A meta-analysis by Song et al30 that included 331 participants 
evaluated postoperative pain using a VAS at different time 
points from the first postoperative day to the day of discharge. 
The VAS score at 6 hours, 24 hours, and 48 hours postop-
eratively showed no significant differences between the two 
techniques.30 In our study, we recorded postoperative pain 
that was significantly lower in the SPAL group than that 
experienced in the MPL group, as evidenced by lower mean 
scores on the VAS. The Song et al30 meta-analysis showed 
that the operative time was longer in the SPAL group than in 
the MPL group, but this difference was not considered to be 
statistically significant. In our study, we obtained lower opera-
tive times with SPAL-BSO compared to MPL. We clearly 
demonstrated that single-port entry is significantly more rapid 
than the creation of a pneumoperitoneum and the insertion 
of an umbilical trocar and 2–3 suprapubic ancillary trocars. 
Finally, we showed that SPAL surgery offers the advantage 
of faster and easier extraction of the surgical specimens. In 
fact, the single access localized at the level of the umbilicus 
is broader in comparison to those that are performed for tra-
ditional laparoscopic surgery. This allows for more rapid and 
easier extraction, without the need for fragmentation of the 
surgical specimen and enlargement of the sites of insertion 
of the trocar; this results in a significantly shorter time than 
conventional laparoscopy for this phase of the surgery. 
Conclusion
SPAL-BSO is feasible and safe with favorable surgical and 
cosmetic outcomes compared to conventional MPL. The 
SPAL approach may be ideal for BRCA mutation carriers 
and breast cancer patients because of its short convalescence, 
minimal interruption in any ongoing cancer treatment, and 
the benefits from improved cosmetics and pain. Prospective 
randomized controlled trials are needed in the future to assess 
the benefits of SPAL compared to MPL.
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